Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVAAA: Allogeneic MSCs for Abdominal Aortic Aneurysm
NCT02846883Phase 1Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2016
- Primary completion
- Sep 2021
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Provacel in abdominal aortic aneurysm (AAA) (3 arms), sponsored by VA Office of Research & Development. Primary endpoint: Changes in Circulating Inflammatory Cell Phenotypes as Measured by Mass Cytometry at 12 months. Started Dec 2016; status: terminated.
02
Drugs
Provacel
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT02846883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02846883.